BioCentury | Oct 29, 2020
Finance

Oct. 28 Quick Takes: Mirati raises $800M on KRAS data; BMS-insitro, Novartis-Molecular Partners, Genecast, Gracell, PureTech, Cerevel, Biodesix

...to forgo royalties in lower income countries.Genecast raises over $149M in series ECancer diagnostics play Genecast Biotechnology Co. Ltd....
...sell 4.2 million shares, a postmoney valuation of $445.6 million. BC Staff Molecular Partners AG Biodesix Inc. Novartis AG insitro Gracell Biotechnologies Genecast Biotechnology PureTech...
BioCentury | Nov 7, 2019
Financial News

Nov. 6 Financial Quick Takes: NEA backs Shape's series A; plus Royalty-Eisai-Epizyme, Sinomed, Genecast and Cadence

...that elute sirolimus, a generic mTOR inhibitor. Genecast raises $43M series D Cancer diagnostics company Genecast Biotechnology Co. Ltd....
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...for tests to guide treatment decisions and cancer heritability analysis; personalized ctDNA-based cancer monitoring $25 GeneCast Biotechnology...
BioCentury | Feb 17, 2017
Financial News

GeneCast completes venture financing

...On Feb. 9, cancer diagnostics company GeneCast Biotechnology Co. (Beijing, China) raised $18 million in a series...
...Precision Medicine Fund and Loyal Valley Innovation Capital also participated. GeneCast Biotechnology Co. , Beijing, China Alicia Parker GeneCast Biotechnology...
BioCentury | Feb 16, 2017
Financial News

GeneCast raises $18M series B round

...Cancer diagnostics company GeneCast Biotechnology Co. (Beijing, China) raised $18 million in a series B round led...
...GeneCast markets genetic detection and diagnostic products for lung, colon, digestive tract and gynecological cancers. Paul Bonanos Genecast Biotechnology...
Items per page:
1 - 5 of 5
BioCentury | Oct 29, 2020
Finance

Oct. 28 Quick Takes: Mirati raises $800M on KRAS data; BMS-insitro, Novartis-Molecular Partners, Genecast, Gracell, PureTech, Cerevel, Biodesix

...to forgo royalties in lower income countries.Genecast raises over $149M in series ECancer diagnostics play Genecast Biotechnology Co. Ltd....
...sell 4.2 million shares, a postmoney valuation of $445.6 million. BC Staff Molecular Partners AG Biodesix Inc. Novartis AG insitro Gracell Biotechnologies Genecast Biotechnology PureTech...
BioCentury | Nov 7, 2019
Financial News

Nov. 6 Financial Quick Takes: NEA backs Shape's series A; plus Royalty-Eisai-Epizyme, Sinomed, Genecast and Cadence

...that elute sirolimus, a generic mTOR inhibitor. Genecast raises $43M series D Cancer diagnostics company Genecast Biotechnology Co. Ltd....
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...for tests to guide treatment decisions and cancer heritability analysis; personalized ctDNA-based cancer monitoring $25 GeneCast Biotechnology...
BioCentury | Feb 17, 2017
Financial News

GeneCast completes venture financing

...On Feb. 9, cancer diagnostics company GeneCast Biotechnology Co. (Beijing, China) raised $18 million in a series...
...Precision Medicine Fund and Loyal Valley Innovation Capital also participated. GeneCast Biotechnology Co. , Beijing, China Alicia Parker GeneCast Biotechnology...
BioCentury | Feb 16, 2017
Financial News

GeneCast raises $18M series B round

...Cancer diagnostics company GeneCast Biotechnology Co. (Beijing, China) raised $18 million in a series B round led...
...GeneCast markets genetic detection and diagnostic products for lung, colon, digestive tract and gynecological cancers. Paul Bonanos Genecast Biotechnology...
Items per page:
1 - 5 of 5